Clinicopathological characteristics and outcomes in men with mesothelioma of the tunica vaginalis testis: analysis of published case-series data
AuthorsGrogg, J. B.
Fronzaroli, J. N.
Bode, P. K.
Sangar, Vijay K
Clarke, Noel W
Fankhauser, Christian D
AffiliationDepartment of Urology, University Hospital Zurich, Frauenklinikstrasse 10, 8091, Zurich, Switzerland.
MetadataShow full item record
AbstractPurpose: Mesothelioma of the tunica vaginalis testis (MTVT) is a rare tumor, and currently, there are no published treatment recommendations. Methods: We performed a systematic literature review and synthesized clinical presentation, clinicopathological factors associated with metastatic disease, treatment options, and outcomes in men with MTVT. Results: We included 170 publications providing data on 275 patients. Metastatic disease occurred in 84/275 (31%) men with malignant MTVT: Most common sites included retroperitoneal lymph nodes (LNs) (40/84, 48%), lungs (30/84, 36%), and inguinal LNs (23/84, 27%). Invasion of the spermatic cord or scrotum was the only risk factor for local recurrence [odds ratio (OR) 3.21, 95% confidence interval (CI) 1.36-7.57]. Metastatic disease was associated with age ≥ 42 years (OR 3.02, 95% CI 1.33-6.86), tumor size ≥ 49 mm (OR 6.17, 95% CI 1.84-20.74), presence of necrosis (OR 8.31, 95% CI 1.58-43.62), high mitotic index (OR 13.36, 95% CI 1.53-116.51) or angiolymphatic invasion (OR 3.75, 95% CI 1.02-13.80), and local recurrence (OR 4.35, 95% CI 2.00-9.44). Complete remission in the metastatic setting was observed in five patients, most of whom were treated with multimodal therapy. Median survival in patients with metastatic disease was 18 months (IQR 7-43). Conclusion: Malignant MTVT is a rare but aggressive disease. Since local recurrence is a risk factor for metastatic progression, we recommend aggressive local treatment. Survival and response to any treatment in the metastatic setting are limited.
CitationGrogg JB, Fronzaroli JN, Oliveira P, Bode PK, Lorch A, Issa A, et al. Clinicopathological characteristics and outcomes in men with mesothelioma of the tunica vaginalis testis: analysis of published case-series data. J Cancer Res Clin Oncol. 2021.
JournalJournal of Cancer Research and Clinical Oncology
- Risk factors and treatment outcomes of 239 patients with testicular granulosa cell tumors: a systematic review of published case series data.
- Authors: Grogg JB, Schneider K, Bode PK, Kranzbühler B, Eberli D, Sulser T, Beyer J, Lorch A, Hermanns T, Fankhauser CD
- Issue date: 2020 Nov
- Comments on a recent case-control study of malignant mesothelioma of the pericardium and the tunica vaginalis testis.
- Authors: Mezei G, Chang ET, Mowat FS, Moolgavkar SH
- Issue date: 2021 Jan 1
- Malignant mesothelioma of the tunica vaginalis testis: review of the literature and assessment of prognostic parameters.
- Authors: Plas E, Riedl CR, Pflüger H
- Issue date: 1998 Dec 15
- Sertoli Cell Tumors of the Testes: Systematic Literature Review and Meta-Analysis of Outcomes in 435 Patients.
- Authors: Grogg J, Schneider K, Bode PK, Kranzbühler B, Eberli D, Sulser T, Lorch A, Beyer J, Hermanns T, Fankhauser CD
- Issue date: 2020 Jul
- Malignant mesothelioma of tunica vaginalis testis: Report of a very rare case with review of the literature.
- Authors: Trenti E, Palermo SM, D'Elia C, Comploj E, Pycha A, Carella R, Pycha A
- Issue date: 2018 Sep 30